EPISODE · Jul 9, 2026 · 4 MIN
Astrazeneca's Trial, Schott Pharma Up, Rheinmetall Sinks
from Stock Movers · host iHeartPodcasts
Today's biggest winners and losers in the stock market.On this episode of Stock Movers:- AstraZeneca and Ionis Pharmaceuticals Inc.’s gene silencer drug Wainua failed to help prevent heart problems in patients with a rare and potentially fatal disease of the organ. AstraZeneca’s shares slumped.- Schott Pharma shares jump by a record 22% after the company improved its guidance for the full year, prompting an upgrade at RBC Capital Markets. The stock is trading at its highest level since October. - Bulgaria’s government may not be able to secure funding for joint project with Rheinmetall for NATO-standard shell, gunpowder plant, Mediapool news website reports, citing Economy Minister Alexander Pulev.See omnystudio.com/listener for privacy information.
Embed this episode
NOW PLAYING
Astrazeneca's Trial, Schott Pharma Up, Rheinmetall Sinks
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.